AVA-7500

N/A

Report date: 2025/01/26 18:07:20

Base Information

Drug NameAVA-7500
Drug Alias Nametumor microenvironment-activated drug conjugate (Avacta/Tufts University School of Medicine)AVA-7500
ClassificationBiologics
Mechanisms of ActionProlyl endopeptidase FAP stimulants
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A